Determination of sensitivity to cytostatic preparations during chemotherapy of malignant tumors
Stepankovskaia, G.K.; Milianovskiĭ, A.I.; Frolova, G.D.
Vrachebnoe Delo 2: 109-112
1977
ISSN/ISBN: 0049-6804 PMID: 860438 Document Number: 118284
Document emailed within 1 workday
Related Documents
Ludwig, H.; Fritz, E. 1981: Individualized chemotherapy in multiple myeloma by cytostatic drug sensitivity testing of colony-forming stem cells Anticancer Research 1(6): 329-334Quäck, J. 1973: Cytostatic therapy of malignant tumors from radiological point of view Die Medizinische Welt 24(47): 1845-1848
Zwicker, H.; Gürtler, J. 1976: The efficacy of cytostatic therapy for malignant tumors as determined by x-rays Rontgen-Blatter; Zeitschrift für Rontgen-Technik und Medizinisch-Wissenschaftliche Photographie 29(8): 365-373
Marek, K. 1972: Trial of cytostatic therapy of malignant brain tumors in adults Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 110(1): 27-43
Král, V.; Hajdúch, M.; Neoral, C.; Klein, J.; Mihál, V.; Orel, M.; Aujeský, R.; Vyslouzil, K.; Cwiertka, K.; Kolek, V.; Nosková, V. 2000: Significance and possibilities of cytostatic treatment of malignant tumors: testing the effects of cytostatics Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 79(3): 134-138
Furuse, K.; Morimoto, K.; Yamamoto, K.; Orito, T. 1989: Application of preoperative chemotherapy to postoperative chemotherapy in malignant bone and soft tissue tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt: 2-3): 1749-1754
Plasse, T.F. 1982: Testing sensitivity of tumors to chemotherapy Mayo Clinic Proceedings 57(11): 728-729
Bychkov, M.B. 1996: Chemotherapy of malignant tumors Arkhiv Patologii 58(4): 15-17
Seidenglanz, G. 1970: Chemotherapy of malignant tumors. 44 Pharmazeutische Praxis 6: 122-138
Ehrhart, H. 1973: Chemotherapy of malignant tumors Münchener Medizinische Wochenschrift 115(18): 814-832
Ushio, Y.; Mogami, H. 1987: Chemotherapy of malignant brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(12): 3227-3233
Brunner, K.W.; Wagner, H.P. 1979: Chemotherapy of malignant skeletal tumors Therapeutische Umschau. Revue Therapeutique 36(7): 653-656
Weissbach, L.; Jaeger, N.; Hartlapp, J.H.; Boedefeld, E.A.; Vahlensieck, W. 1983: Chemotherapy of malignant testicular tumors Der Urologe. Ausg. a 22 Suppl: 310-321
Stieglmayr, F.S. 1973: Chemotherapy of malignant brain tumors Wiener Medizinische Wochenschrift 123(44): 637-642
D'iakov, S.I.; Lebedeva, I.K.; Sidorenko, S.V. 1996: Modern methods and means for the rapid determination of the sensitivity of the causative agents of dangerous infectious diseases to antibiotics and chemical preparations Voenno-Meditsinskii Zhurnal 317(3): 44-47
Nomura, K.; Nagane, M.; Shibui, S. 1992: Chemo-sensitivity test for malignant brain tumors by DNA histogram, in vitro Nihon Rinsho. Japanese Journal of Clinical Medicine 50(10): 2374-2380
Röttinger, E.M. 1995: Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(5): 303-304
Takeshima, H.; Kuratsu, J.-i. 2003: Evolution of chemotherapy for malignant brain tumors No Shinkei Geka. Neurological Surgery 31(7): 725-734
Dement'eva, N.P. 1988: Nitrosomethylurea in the clinical chemotherapy of malignant tumors Voprosy Onkologii 34(1): 8-17
Orekhovich, V.N.; Abakumova, O.I.; Kazakova, O.V.; Lerman, M.I. 1977: Proteinases and chemotherapy of malignant human tumors Vestnik Akademii Meditsinskikh Nauk SSSR 10: 24-29